# Norio Nonomura

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/norio-nonomura/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,947 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 61 |
| i10-index | 359 |
| Last Known Institution | Osaka Gakuin University |
| OpenAlex ID | https://openalex.org/A5088384086 |
| ORCID iD | https://orcid.org/0000-0002-6522-6233 |
| Works | 1,216 |

## Researcher papers

- [Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/everolimus-for-angiomyolipoma-associated-with-tuberous-sclerosis-complex-or/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Osaka Gakuin University](https://scholariq.org/institutions/osaka-gakuin-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.